Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: A multicenter, randomized, double-blind, 24-week study

Clinical Therapeutics

Volumn 27, Issue 2, 2005, Pages 166-173

  Otero, Manuel Luque ^a   Claros, Nieves Martell ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Ambulatory blood pressure monitoring; Diabetes mellitus; Enalapril; Hypertension; Manidipine

Indexed keywords

CREATININE; ENALAPRIL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANIDIPINE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHONIA; ESSENTIAL HYPERTENSION; FEMALE; FLUSHING; GLUCOSE BLOOD LEVEL; HEADACHE; HEART FAILURE; HEART RATE; HEMOGLOBIN DETERMINATION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 16244375580     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.02.001     Document Type: Article

References (21)

1. Instituto Nacional de Estadistica. Defunciones segun la Causa de Muerte. Available at: http://www.ine.es/inebase/menu2.html, Accessed March 13, 2004
2. Banegas Banegas J.R., Rodriguez-Artalejo F., and de la Cruz Troca J.J. Hypertension-related mortality and arterial pressure in Spain [in Spanish] Med Clin (Barc) 112 1999 489 494
3. Almodovar C.G., Carreira J., Panadero J., and Luque Otero M. Association of metabolic risk factors and blood pressure in a natural population (Mora de Toledo) [in Spanish] Aten Primaria 17 1996 458 462
4. Tarnow L., Rossing P., and Gall M.A. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V Diabetes Care 17 1994 1247 1251
5. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
6. Hansson L., Zanchetti A., Carruthers S.G. HOT Study Group Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial Lancet 351 1998 1755 1762
7. [published corrections appear in J Hypertens. 2003;21: 2203-2204 and J Hypertens. 2004;22:435] European Society of Hypertension-European Society of Cardiology Guidelines Committee 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 21 2003 1011 1053
8. [published correction appears in JAMA. 2003;290:197] Chobanian A.V., Bakris G.L., Black H.R. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report JAMA 289 2003 2560 2572
9. Pool J.L. Is it time to move to multidrug combinations? Am J Hypertens 16 2003 365 405
10. Maki D.D., Ma J.Z., Louis T.A., and Kasiske B.L. Long-term effects of anti hypertensive agents on proteinuria and renal function Arch Intern Med 155 1995 1073 1080
11. Tuomilehto J., Rastenyte D., and Birkenhüger W.H. Systolic Hypertension in Europe Trial Investigators Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension N Engl J Med 340 1999 677 684
12. Cheer S.M., and McClelland K. Manidipine: A review of its use in hypertension Drugs 61 2001 1777 1799
13. Zanchetti A., Omboni S., and La Combare P. Efficacy, tolerability, and impact on quality of life and long-term treatmentwith manidipine or amlodipine in patients with essential hypertension J Cardiouasc Pharmacol 38 2001 642 650
14. Omboni S., Parati G., Zanchetti A., and Mancia G. Calculation of trough:peak ratio of anti hypertensive treatment from ambulatory blood pressure: Methodological aspects J Hypertens 13 1995 1105 1112
15. Mancia G., Omboni S., and Agabiti-Rosei E. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients J Cardiouasc Pharmacol 35 2000 926 931
16. Shiba T., Inoue M., and Tada H. Delapril versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy Diabetes Res Clin Pract 47 2000 97 104
17. Haffner S.M., Lehto S., and Ronnemaa T. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
18. Bengtsson C., Blohme G., and Lapidus L. Do anti hypertensive drugs precipitate diabetes? Br Med J (Clin Res Ed) 289 1984 1495 1497
19. Skarfors E.T., Lithell H.O., Selinus I., and Aberg H. Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ 298 1989 1147 1152
20. Zanchetti A., and Ruilope L.M. Antihypertensive treatment in patients with type-2 diabetes mellitus: What guid ance from recent controlled randomized trials? J Hypertens 20 2002 2099 2110
21. Abstract Fogari R., Malamani G.D., and Zoppi A. Manidipine has less oedematigenous potential than amlodipine Am J Hypertens 13 Suppl 1 2000 S131